To investigate the correlation between retinol binding protein 4 (RBP4), lipoprotein associated phospholipase A2 (LP-PLA2), we studied the clinical phenotype of coronary heart disease (CHD) and the severity of coronary artery disease. Our studies showed that the changes of retinol binding protein 4, LP-PLA2 serum concentration has a relation with the severity of coronary artery disease progression, but no clear relationship with the degree of coronary artery lesion and count. Furthermore, LP-PLA2 concentration increases with the increase of the severity of coronary artery disease and disease occurrences.
Published in | Clinical Medicine Research (Volume 6, Issue 4) |
DOI | 10.11648/j.cmr.20170604.13 |
Page(s) | 131-134 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2017. Published by Science Publishing Group |
Retinol Binding Protein 4, Lipoprotein Associated Phospholipase A2, Coronary Heart Disease, Coronary Artery Lesion Degree
[1] | Guo Jifang, Kong Fanhe. Retinol binding protein 4 and coronary heart disease correlation. Mudanjiang Medical College, 2013, 34: 12-14. |
[2] | Maiolino G, Pedon L, Cesari M, et al. Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high rick coronary artery disease patients. PLOS One, 2012, 7(10): e48171. |
[3] | Han Yaling. Chang'an International Cardiovascular Forum. Chinese percutaneous coronary intervention guidelines. Chinese Journal of Cardiology, 2012, 40 (4): 252-254. |
[4] | Li F, Xia K, Sheikh MS, et al. Retinol binding protein 4 promotes hyperinsulinism-induced proliferation of rat aortic smooth muscle cells, Mol Med Rep, 2014, 9 (5): 1634-1640. |
[5] | Ge Ling, Cheng Xunmin, YANG Song, et al. Retinol binding protein 4 and lipoprotein-associated phospholipase A2 levels and coronary heart disease and coronary artery disease characteristics of the correlation analysis. Bengbu Medical College, 40 (8): 1102-1104. |
[6] | Fortunato J, Bláha V, Bis J, et al. Lipoprotein-associated phospholipase A2 mass level is increased in elderly subjects with type 2 diabetes mellitus. J Diabetes Res, 2014, 2014: 278063. |
[7] | Caslake M J, Packard C J. Lipoprotein –associated phospholipase A2 (platelet-activating factoracetylhydrolase) and cardiovascular disease. Curr Opin Lipidol, 2003, 14 (4): 347-352. |
[8] | Zhao Yong, Guo Zhibin. The value of lipoprotein-associated phospholipase A2 in predicting the risk of coronary heart disease. Journal of Applied Clinical Medicine, 2014, 15 (12): 1-3. |
[9] | Ferguson J F, Hinkle CC, Mehta NN, et al. Translational studies of lipoprotein-associated phospholipase A2 in inflammation and atherosclerosis. J AM Coll Cardiol, 2012, 59 (8): 764-772. |
[10] | Liu Hai-liang, Li Guo-qing. Relationship between serum retinol-binding protein-4 and high-sensitivity C-reactive protein in patients with coronary heart disease. Journal of Clinical Internal Medicine, 2011, 28 (2): 92-94. |
[11] | Liu Xingjia, Zheng Xing, Qin Yongwen, et al. Lipoprotein-related phospholipase A2 activity in response to coronary angiography sclerosis degree, Journal of the Second Military Medical University, 2006, 27: 391-395. |
[12] | Cai A, Li G, Chen J, et al. Increased serum level of LP-PLA2 is independentiy associatated with the severity of coronary artery diseases: a cross-sectional study of Chinese population. BMC Cardiovasc Disord, 2015, 15 (1): 14. |
[13] | Wang Lili, Lei Changcheng. Lipoprotein-related phospholipase A2 and coronary heart disease related research progress. Modern Medicine and Health, 2015, 31 (1): 57-60. |
[14] | Pan Chen-liang, Peng Yu, Hu Xue-ting, et al. Correlation between lipoprotein-associated phospholipase A2 and acute syndromes. Clinical Cardiovascular Diseases, 2014, 30 (11): 962-965. |
[15] | Kolodgie F D, Burke A P, Skorija K S, et al. Lipoprotein –associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol, 2006, 26: 2523-2529. |
APA Style
Liu-qiang Lv, Yang-zhang Tang, Shi-qiang Wang, Gui Ren, Yu-Chen Lo, et al. (2017). Novel Discovery of the Relationship of Clinical Phenotype of Coronary Heart Disease with Retinol Binding Protein 4, Lipoprotein-Related Phospholipase A2. Clinical Medicine Research, 6(4), 131-134. https://doi.org/10.11648/j.cmr.20170604.13
ACS Style
Liu-qiang Lv; Yang-zhang Tang; Shi-qiang Wang; Gui Ren; Yu-Chen Lo, et al. Novel Discovery of the Relationship of Clinical Phenotype of Coronary Heart Disease with Retinol Binding Protein 4, Lipoprotein-Related Phospholipase A2. Clin. Med. Res. 2017, 6(4), 131-134. doi: 10.11648/j.cmr.20170604.13
AMA Style
Liu-qiang Lv, Yang-zhang Tang, Shi-qiang Wang, Gui Ren, Yu-Chen Lo, et al. Novel Discovery of the Relationship of Clinical Phenotype of Coronary Heart Disease with Retinol Binding Protein 4, Lipoprotein-Related Phospholipase A2. Clin Med Res. 2017;6(4):131-134. doi: 10.11648/j.cmr.20170604.13
@article{10.11648/j.cmr.20170604.13, author = {Liu-qiang Lv and Yang-zhang Tang and Shi-qiang Wang and Gui Ren and Yu-Chen Lo and Hiroshi Honda and Edward J. Parish}, title = {Novel Discovery of the Relationship of Clinical Phenotype of Coronary Heart Disease with Retinol Binding Protein 4, Lipoprotein-Related Phospholipase A2}, journal = {Clinical Medicine Research}, volume = {6}, number = {4}, pages = {131-134}, doi = {10.11648/j.cmr.20170604.13}, url = {https://doi.org/10.11648/j.cmr.20170604.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20170604.13}, abstract = {To investigate the correlation between retinol binding protein 4 (RBP4), lipoprotein associated phospholipase A2 (LP-PLA2), we studied the clinical phenotype of coronary heart disease (CHD) and the severity of coronary artery disease. Our studies showed that the changes of retinol binding protein 4, LP-PLA2 serum concentration has a relation with the severity of coronary artery disease progression, but no clear relationship with the degree of coronary artery lesion and count. Furthermore, LP-PLA2 concentration increases with the increase of the severity of coronary artery disease and disease occurrences.}, year = {2017} }
TY - JOUR T1 - Novel Discovery of the Relationship of Clinical Phenotype of Coronary Heart Disease with Retinol Binding Protein 4, Lipoprotein-Related Phospholipase A2 AU - Liu-qiang Lv AU - Yang-zhang Tang AU - Shi-qiang Wang AU - Gui Ren AU - Yu-Chen Lo AU - Hiroshi Honda AU - Edward J. Parish Y1 - 2017/06/29 PY - 2017 N1 - https://doi.org/10.11648/j.cmr.20170604.13 DO - 10.11648/j.cmr.20170604.13 T2 - Clinical Medicine Research JF - Clinical Medicine Research JO - Clinical Medicine Research SP - 131 EP - 134 PB - Science Publishing Group SN - 2326-9057 UR - https://doi.org/10.11648/j.cmr.20170604.13 AB - To investigate the correlation between retinol binding protein 4 (RBP4), lipoprotein associated phospholipase A2 (LP-PLA2), we studied the clinical phenotype of coronary heart disease (CHD) and the severity of coronary artery disease. Our studies showed that the changes of retinol binding protein 4, LP-PLA2 serum concentration has a relation with the severity of coronary artery disease progression, but no clear relationship with the degree of coronary artery lesion and count. Furthermore, LP-PLA2 concentration increases with the increase of the severity of coronary artery disease and disease occurrences. VL - 6 IS - 4 ER -